SAM
SRRA

Shell Asset Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Shell Asset Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,107
Closed -$116K – 1417
2022
Q2 		$116K Buy
+2,107
New +$111K ﹤0.01% 1251

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Shell Asset Management's SRRA Position: Q3 2022 in Review

Shell Asset Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 2,107 shares — an estimated $116K sold.

Shell Asset Management first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $116K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Shell Asset Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Shell Asset Management sold 2,107 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $116K.
  • Shell Asset Management first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Shell Asset Management's Sierra Oncology, Inc. Common Stock position peaked at $116K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Shell Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.